PREDETERMINATION BY INFECTION AND BY VACCINATION OF ANTIBODY RESPONSE TO INFLUENZA VIRUS VACCINES (original) (raw)

J Exp Med. 1957 Nov 30; 106(6): 835–850.

From the Department of Epidemiology and Virus Laboratory, School of Public Health, University of Michigan, Ann Arbor

Copyright © Copyright, 1957, by The Rockefeller Institute for Medical Research New York

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).

Abstract

The antibody orienting effects of prior infections with antigenic variants of influenza viruses were confirmed by studies with monovalent adjuvant vaccines and with polyvalent aqueous and adjuvant preparations. In either case, the predominant antibody response was of a "booster" type, directed against the major antigens of strains of original infection. It was shown that vaccination with appropriate strains, selected as antigenic prototypes, could orient or predetermine subsequent antibody response upon revaccination. Moreover, the effects of exposure by vaccination were found to be durable and to constitute a foundation upon which future antibody dividends could be accumulated. As a result, it seems feasible to induce by vaccination a more lasting broad composite antibody protection against influenza if appropriate preparations and schedules are used.

Full Text

The Full Text of this article is available as a PDF (974K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.


Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press